OurCrowd

JUNE 18, 2020

Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that it will host a key opinion leader (KOL) call on digital therapeutics for the management of diabetes and other chronic conditions on Tuesday, June 23, 2020 at 10:30 a.m. The post [DarioHealth in Yahoo Finance] Dario Health to Host Key Opinion Leader Call on Digital Therapeutics for the Management of Diabetes and Other Chronic Conditions appeared first on OurCrowd.

digital therapeutics 28

digital therapeutics health financing finance 28

OurCrowd

SEPTEMBER 23, 2019

NASDAQ: DRIO) (“DarioHealth” or “Dario”), a leading, global digital therapeutics company, today announced that Erez Raphael, DarioHealth’s Chief Executive Officer, will be a speaker at the second annual DTx East 2019 conference taking place at Harvard Medical School in Boston, MA from September 24-26, 2019. DarioHealth Corp.

digital therapeutics 28

digital therapeutics 28

OurCrowd

AUGUST 13, 2020

Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that an emerging science industry poster has been accepted for presentation at the virtual Association of Diabetes Care and Education Specialists (ADCES) 2020 Annual Conference, Read more here.

digital therapeutics 36

digital therapeutics education financing finance 36

OurCrowd

AUGUST 11, 2019

NASDAQ: DRIO) (“DarioHealth” or “Dario”), a leading global, digital therapeutics company, presented new clinical data yesterday at the American Association of Diabetes Educators (“AADE”) conference in Houston, Texas, which showed remarkable improvements in average blood-glucose levels and in-range measurements in patients with diabetes using Dario’s digital therapeutics platform and dedicated one-on-one personal health coaching.

digital therapeutics 30

digital therapeutics health education 30

OurCrowd

JUNE 14, 2020

Medisafe, a leading digital therapeutics company providing medication management solutions for patients across the healthcare continuum, announced a partnership with the Everyday Health Group, a recognized leader in patient and provider education and services.

digital therapeutics 30

digital therapeutics education health 30

OurCrowd

MAY 13, 2020

BOSTON, May 13, 2020 /PRNewswire/ — Medisafe, a leading digital therapeutics company providing medication management solutions for patients across the healthcare continuum, today announced a partnership with the Everyday Health Group, a recognized leader in patient and provider education and services.

digital therapeutics 30

digital therapeutics education health 30

OurCrowd

JANUARY 13, 2020

Medisafe, a leading evidenced-based digital therapeutics company collaborating with healthcare organizations to provide medication management solutions for patients, today announced their new capabilities to integrate pharmacy services providing the last mile of services and completing a holistic patient journey management solution for medication management.

digital therapeutics 28

digital therapeutics collaboration 28

OurCrowd

OCTOBER 7, 2020

Digital therapeutics companion platform Medisafe has deployed its new Maestro platform, which aims to orchestrate medication adherence journeys with precision and speed and create personalized patient support resources.

digital therapeutics 39

digital therapeutics support 39

OurCrowd

MAY 6, 2020

Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings, limit COVID-19 exposure, and preserve personal protective equipment (PPE), the U.S. NEW YORK, May 6, 2020 /PRNewswire/ — DarioHealth Corp.

digital therapeutics 28

digital therapeutics innovation hospitality financing 28

OurCrowd

MAY 4, 2020

Nasdaq: DRIO), a leading global digital therapeutics (DTx) innovator, announced today that it has expanded its offering on its chronic care platform application to include behavioral health coaching for stress, anxiety and loneliness, conditions which have recently escalated due to COVID-19 social distancing restrictions including “shelter-in-place” and “stay-at-home” orders. NEW YORK, May 4, 2020 /PRNewswire/ — DarioHealth Corp.

digital therapeutics 28

digital therapeutics innovation health financing 28

OurCrowd

FEBRUARY 24, 2020

NASDAQ: DRIO), a pioneer in the global digital therapeutics market, announced today the launch of its digital therapeutics solution for managing chronic diseases such as diabetes and hypertension on Albertsons Marketplace. The post [DarioHealth in Yahoo Finance] DarioHealth Digital Diabetes Management System is Now Available at Albertsons appeared first on OurCrowd. DarioHealth Corp.

digital therapeutics 28

digital therapeutics financing finance 28

OurCrowd

MAY 6, 2020

Nasdaq: DRIO), a global digital therapeutics (DTx) innovator, announced today that in an effort to reduce contact between healthcare providers and patients in hospital settings, limit COVID-19 exposure, and preserve personal protective equipment (PPE), the U.S. DarioHealth Corp.

digital therapeutics 28

digital therapeutics innovation hospitality health 28

Angel Capital Association

MAY 18, 2020

MedRhythms, a Portland, Maine-based digital therapeutics company, is building direct stimulation, prescription therapeutics that use sensors, music, and software to improve loss of mobility caused by neurologic injuries and diseases. The digital therapeutic platform is designed to digitize an evidence-based intervention known as Rhythmic Auditory Stimulation ( see MedRhythms Scientific Approach Summary ).

digital therapeutics 40

digital therapeutics hospitality angel capital health 40

OurCrowd

SEPTEMBER 16, 2020

Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announces that Eric Milledge has joined DarioHealth as Chairman of the company’s newly-established Scientific Advisory Board (SAB). DarioHealth Corp.

digital therapeutics 36

digital therapeutics board financing finance 36

OurCrowd

SEPTEMBER 9, 2020

Medisafe, a leading digital therapeutics companion platform, today announced the immediate deployment of its new Medisafe Maestro platform.

digital therapeutics 39

digital therapeutics support technology 39

OurCrowd

SEPTEMBER 15, 2020

a multi-billion-dollar diabetes franchise previously owned by Johnson & Johnson (JNJ) Scientific Advisory Board will help develop and execute the Company’s strategic roadmap for refining, improving and expanding its digital therapeutics platform.

digital therapeutics 36

digital therapeutics board development 36

OurCrowd

SEPTEMBER 10, 2020

Medisafe, a Boston, MA-based digital therapeutics companion platform, announced the immediate deployment of its new Medisafe Maestro platform.

digital therapeutics 36

digital therapeutics consulting support technology 36

OurCrowd

NOVEMBER 15, 2019

Nasdaq: DRIO) (“DarioHealth” or “Dario”), a leading global, digital therapeutics company, presented new clinical data yesterday at the 19th Annual Diabetes Technology Meeting (“DTM”) conference in Bethesda, Maryland, which showed remarkable improvements in average blood glucose levels (BGavg) and in-range measurements in patients with diabetes using Dario’s digital therapeutics platform and dedicated one-on-one personal health coaching.

digital therapeutics 28

digital therapeutics health technology 28

OurCrowd

DECEMBER 22, 2019

The Israeli company plans to use some of the funding to increase the breadth of chronic conditions addressed by DarioHealth’s digital therapeutics platform. Read more here. The post [DarioHealth in Globes] DarioHealth raises $21.3m in private placement appeared first on OurCrowd. News Center ourcrowd fund OurCrowd Qure portfolio news

digital therapeutics 28

digital therapeutics 28

OurCrowd

APRIL 5, 2020

BOSTON, April 6, 2020 /PRNewswire/ — Medisafe, a leading digital therapeutics companion company providing medication management solutions for patients across the healthcare continuum, today announced the immediate deployment of on-demand and ongoing support for patients worldwide facing new challenges as a result of COVID-19.

digital therapeutics 28

digital therapeutics support financing finance 28

OurCrowd

NOVEMBER 15, 2019

DarioHealth’s digital therapeutics platform delivers personalized, evidence-based interventions to users that are driven by precision data analytics, high quality software and one-on-one coaching, which are all available through Dario’s suite of membership plans. The post [DarioHealth in PR Newswire] DarioHealth Clinical Study Data Highlights the Material Benefit Digital Interventions Have on Glycemic Control in Users with Diabetes appeared first on OurCrowd.

digital therapeutics 28

digital therapeutics 28

OurCrowd

JULY 30, 2019

DarioHealth, a leading global, digital therapeutics company, announced today the addition of a new digital monitoring solution on its Dario app platform that will allow patients to monitor their blood pressure throughout the day, in addition to their blood glucose levels.

digital therapeutics 28

digital therapeutics 28

OurCrowd

JULY 30, 2019

Nasdaq: DRIO), (“DarioHealth” or “Dario”), a leading global, digital therapeutics company, announced today the addition of a new digital monitoring solution on its Dario app platform that will allow patients to monitor their blood pressure throughout the day, in addition to their blood glucose levels. DarioHealth Corp.

digital therapeutics 28

digital therapeutics 28

OurCrowd

OCTOBER 24, 2019

DarioHealth Corp. (“DarioHealth” or “Dario”) (DRIO), a leading, global digital therapeutics company, today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office titled “Systems and Methods for Enabling Optical Transmission of Data Between a Sensor and a Smart Device.” ” Read more here. The post [DarioHealth in Yahoo Finance] DarioHealth Awarded U.S.

digital therapeutics 30

digital therapeutics enablement financing finance 30

OurCrowd

SEPTEMBER 18, 2019

DarioHealth Corp. (“DarioHealth” or “Dario”) (DRIO), a leading, global digital therapeutics company, today announced that it has received a notice of allowance from the U.S. Patent and Trademark Office titled “Systems and Methods for Enabling Optical Transmission of Data Between a Sensor and a Smart Device.” ” Read more here. The post [DarioHealth in Yahoo Finance] DarioHealth Awarded U.S.

digital therapeutics 28

digital therapeutics enablement financing finance 28

OurCrowd

AUGUST 15, 2019

DarioHealth Corp. (“DarioHealth” or “Dario”) (DRIO), a leading, global digital therapeutics company, today announced an alliance with DigitalHealth.London (“DH.L”) ”) as part of its UK Israel Dangoor Health Initiative (the “Initiative”), which aims to partner leading Israeli digital health companies with the UK National Health Service (NHS) to benefit patients.

digital therapeutics 28

digital therapeutics health financing finance 28